Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Anxiety Disorders 5 Breast Neoplasms 4 Pain 3 Fatigue 2 Depression 2 Vulvar Neoplasms 1 Vomiting 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stress, Psychological 1 Rectal Neoplasms 1 Personal Satisfaction 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Myasthenia Gravis 1 Malignant Solid Neoplasm 1 Inflammation 1 Hematopoietic and Lymphatic System Neoplasm 1 Femininity 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Cancer Pain 1 A Healthcare Professional, a Patient or Caregiver in the Radiation Oncology Department at the University of Pennsylvania 1

Interventions

Rituximab 7 Pyridostigmine Bromide 5 Prednisone 5 efgartigimod alfa 4 Hizentra 4 telitacicept 3 Immunoglobulins, Intravenous 3 Cyclophosphamide 3 Azathioprine 3 thymoglobulin 2 fludarabine 2 Thymectomy 2 Steroids 2 Mycophenolic Acid 2 Data Collection 2 Blood Specimen Collection 2 zilucoplan 1 tofacitinib 1 tocilizumab 1 talquetamab 1 sargramostim 1 rozanolixizumab 1 prednylidene 1 gamma-Globulins 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 bu-zhong-yi-qi-tang 1 apraclonidine 1 Walk Test 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myasthenia Gravis × Art Therapy × Clear all

NCT07125105 2025-08-15

APART-MG

Universite du Littoral Cote d'Opale

Phase NA Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡